Drug Profile
Carisoprodol sustained-release - MEDA
Latest Information Update: 11 Jul 2012
Price :
$50
*
At a glance
- Originator Meda
- Class Muscle relaxants
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Spasm
Most Recent Events
- 11 Jul 2012 Discontinued - Phase-III for Spasm in USA (PO)